MECHANISMS OF SIGNAL TRANSDUCTION OF CARDIAC OPIOID RECEPTOR STIMULATION

心脏阿片受体刺激的信号传导机制

基本信息

  • 批准号:
    5200356
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Opioid peptides (OP) are coreleased with catecholamines (CA) from nerve terminals in the heart cardiac myocytes also produce and secrete opioids and have opioid peptide receptors (OPR). Thus we proposed that OP also may have a postsynaptic cardiac intracellular signalling role which involves a potent "cross-talk" with the beta-adrenergic receptor (beta-AR) stimulation pathway. The focus of this work was to identify whether OPR stimulation influences the effects of beta-AR stimulation and the nature of the mechanism(s) of interaction. In an intact isolated heart preparation (pretreated with 6-hydroxy-dopamine to deplete CA from peripheral nerve endings) peak systolic pressure was increased to 217% of control by the CA norepinephrine (NE;10-7M), addition of the delta-OPR agonist leucine enkephalin (LE;10-8M) resulted in a marked reduction in developed pressure to 66% of control within 15-25min. The OPR antagonist naloxone (10-8M) added to the LE+NE buffer rapidly reversed the LE effect (<1-2min) to 188% of control systolic pressure. Although 10-8M LE potently inhibited the positive inotropic effect of NE including the stimulated increase in cAMP, alone, at this concentration it had no effect on systolic pressure nor tissue content of cAMP. A non-hydrolyzable analog of cAMP, CPTcAMP, at 3x10-5M increased systolic pressure to 176% of control but LE (10-8M)+CPTcAMP could not counter act the positive inotropic effect. Similarly during perfusion with forskolin, which raised systolic pressure to 200%, 10-8M LE also had no effect. Following pretreatment with pertussis toxin, (which catalyzes the adenine nucleotide ribosylation of Gi/G0-protein alpha subunits and inhibits the response to agonists), LE could no longer inhibit the effects of betaAR stimulation. Similar results were observed in single cardiac myocytes in which cytosolic Ca2+ and Ica could be measured. We conclude that the potent effects of LE are due to a specific "cross-talk" of the LE signalling cascade on the betaAR stimulation pathway and mediated by a pertussis toxin-sensitive G protein involved in the inhibition of adenylyl cyclase. This interaction may thus regulate the magnitude of beta-adrenergic effects on cardiac work and provide protection by preventing metabolic substrate supply/demand imbalance during intense cardiac stress such as exercise or ischemia.
阿片肽(OP)与儿茶酚胺(CA)从神经协同释放 心脏心肌细胞的末端也产生和分泌阿片类物质。 并具有阿片肽受体(OPR)。因此,我们建议OP也 可能具有突触后心脏细胞内信号转导作用 与β-肾上腺素能受体产生强烈的“串音” (β-AR)刺激途径。这项工作的重点是确定 OPR刺激是否影响β-AR刺激的效果 互动机制的本质(S)。在一个完整的孤立的 心脏制剂(用6-羟基多巴胺预处理以从 周围神经末梢)峰值收缩压增加到217% 由CA去甲肾上腺素(NE;10-7M)控制,添加 Delta-OPR激动剂亮氨酸脑啡肽(LE;10-8M)导致显著的 在15-25分钟内将开发压力降低到对照的66%。这个 OPR拮抗剂纳洛酮(10-8M)快速加入LE+NE缓冲液 逆转LE效应(&lt;1-2min)至对照收缩压的188%。 10-8M LE可有效抑制去甲肾上腺素的正性肌力作用 包括仅在这种浓度下,cAMP的刺激增加 对收缩压和cAMP组织含量无明显影响。一个 CAMP的非水解性类似物,CPTcAMP,在3x10-5M时收缩压升高 压力达到对照的176%,但LE(10-8M)+CPTcAMP不能抵消作用 正性变力作用。类似地,在福斯科林灌流期间, 使收缩压升高至200%,10~(-8)M LE也无作用。 在用百日咳毒素(催化腺嘌呤)预处理后 GI/G0蛋白α亚基的核苷酸核糖化并抑制 对激动剂的反应),LE不再能抑制BetaAR的作用 刺激。在单个心肌细胞中也观察到了类似的结果 哪些细胞内钙离子和Ica可以被测量。我们的结论是 LE的潜在影响是由于LE的一种特殊的“串扰” β-AR刺激通路上的信号级联反应 百日咳毒素敏感G蛋白参与抑制 腺苷环化酶。因此,这种相互作用可以调节 β-肾上腺素能对心脏做功的影响并通过 防止紧张期间代谢底物供需失衡 心脏应激,如运动或缺血。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S PEPE其他文献

S PEPE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S PEPE', 18)}}的其他基金

FATTY ACID MODULATION OF L-TYPE CALCIUM CHANNEL FUNCTION IN CARDIAC MYOCYTES
脂肪酸对心肌细胞 L 型钙通道功能的调节
  • 批准号:
    3745551
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
FATTY ACID MODULATION OF L-TYPE CALCIUM CHANNEL FUNCTION IN CARDIAC MYOCYTES
脂肪酸对心肌细胞 L 型钙通道功能的调节
  • 批准号:
    3767876
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY FATTY ACID MODULATION OF MYOCARDIAL FUNCTION AND INFLUENCES ON AGING
膳食脂肪酸对心肌功能的调节及其对衰老的影响
  • 批准号:
    3745550
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY FATTY ACID MODULATION OF MYOCARDIAL FUNCTION AND INFLUENCES ON AGING
膳食脂肪酸对心肌功能的调节及其对衰老的影响
  • 批准号:
    3767875
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISMS OF SIGNAL TRANSDUCTION OF CARDIAC OPIOID RECEPTOR STIMULATION
心脏阿片受体刺激的信号传导机制
  • 批准号:
    2565764
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY FATTY ACID MODULATION OF MYOCARDIAL FUNCTION AND INFLUENCES ON AGING
膳食脂肪酸对心肌功能的调节及其对衰老的影响
  • 批准号:
    5200351
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISMS OF SIGNAL TRANSDUCTION OF CARDIAC OPIOID RECEPTOR STIMULATION
心脏阿片受体刺激的信号传导机制
  • 批准号:
    3745558
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
  • 批准号:
    RGPIN-2021-04040
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
  • 批准号:
    547124-2020
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
  • 批准号:
    547124-2020
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
  • 批准号:
    RGPIN-2021-04040
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
  • 批准号:
    451966
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10455587
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10261394
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
  • 批准号:
    20K08498
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
  • 批准号:
    10380126
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10662279
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了